¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"peripheral nervous system agents"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • remote afterloading system
    ¿ø°ÝÁ¶ÀÛÈÄÀåÁø¹ý
  • reproductive system
    »ý½Ä°èÅë
  • respiratory system
    È£Èí°èÅë
  • reticuloendothelial system
    ±×¹°³»ÇǰèÅë, ¼¼¸Á³»ÇǰèÅë
  • Rh blood group system
    ¾Ë¿¡ÃëÇ÷¾×Çü±º
  • self-system
    ÀÚ±âü°è
  • system
    °èÅë, ÀåÄ¡, Á¦µµ
  • scavenging system
    ¸¶Ãë°¡½ºÁ¦°Åü°è
  • skeletal system
    »À´ë°èÅë
  • social security system
    »çȸº¸ÀåÁ¦µµ
  • somatosensory system
    ¸ö°¨°¢°èÅë
  • sound conduction system
    ¼Ò¸®Àü´Þ°èÅë, ÀüÀ½°è
  • static system
    Á¤Áö°è
  • stereotactic system
    Á¤À§°íÁ¤±â
  • subcortical descending system
    °ÑÁú¹ØÇÏÇà°è, °ÑÁú¹Ø³»¸²°èÅë
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üÁúȯ(¡­Ç÷°üÁúȯ).
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üÁúȯ(ØÇôþúìηòðü´)
  • peripheral vascular resistance
    ¸»ÃÊÇ÷°ü ÀúÇ×.
  • peripheral vasodilation
    ¸»ÃÊÇ÷°üÈ®Àå.
  • peripheral vertigo
    ¸»ÃÊ(¼º) ¾îÁö·³, ¸»ÃÊ(¼º) Çö±â
  • peripheral vertigo
    ¸»Ãʼº ¾îÁö·³, ¸»Ãʼº Çö±â.
  • peripheral vision
    ÁÖº¯½Ã(ñ²Ü«ãÊ).
  • peripheral visual field
    ÁÖº¯½Ã¾ß(ñ²Ü«ãÊå¯).
  • peripheral vocal cord paralysis
    ¸»ÃÊ(¼º) ¼º´ë¸¶ºñ
  • peripheral zone
    ¸»ÃÊ´ë
  • peripheral zone
    ¼ÒÀý°ü(á³ï½Î·).
  • peripheral zone
    ÁÖº¯±¸¿ª
  • pulmonary cyst,peripheral
    ¸»Ãʼº(ØÇôþàõ)
  • total peripheral resistance
    Àü<ÃÑ>¸»ÃÊÀúÇ×(îï<õÅ>ØÇôþî½ù÷)
  • total peripheral resistance
    Àü<ÃÑ>¸»ÃÊÀúÇ×(îï<õÅ>ØÇôþî½ù÷).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
PDS pain-dysfunction syndrome; paroxysmal depolarizing shift; patient data system; Patient-Doctor Societ...
PPS Personal Preference Scale; physician, patient and society [course]; polyvalent pneumococcal polysacc...
RAS rapid atrial stimulation; recurrent aphthous stomatitis; reflex activating stimulus; reliability, av...
SCS Saethre-Chotzen syndrome; shared computer system; silicon-controlled switch; Society of Clinical Sur...
SIS semantic indexing system; serotinin irritation syndrome; simian sarcoma; simulator-induced syndrome;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
PAOD Peripheral arterial occlusive disease
PBzR Peripheral benzodiazepine receptor
PBL Peripheral blood
PBMC Peripheral blood
PBC Peripheral blood cell
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lymphatic system
    ¸²ÇÁ°è
    °¨¿°À̳ª Áúº´°ú ½Î¿ì´Â ¼¼Æ÷¸¦ ¸¸µé°Å³ª ÀúÀåÇÏ´Â Á¶Á÷°ú Àå±â. °ñ¼ö, ºñÀå, Èä¼±, ±×¸®°í ¸²ÇÁÀý µîÀÌ ¸²ÇÁ°èÀÇ ´ëÇ¥Àû Àå±âÀÌ´Ù. ¸²ÇÁ°è¿¡´Â ÀÌ·¯ÇÑ ¿©·¯ Á¶Á÷°ú Àå±â¸¦ ¿¬°áÇÏ´Â Åë·Î Áï ¸²ÇÁ°üÀÌ ÀÖÀ¸¸ç À̸¦ ÅëÇØ ¸²ÇÁ°¡ ¿î¹ÝµÈ´Ù.
  • lymphoreticular system
    ¸²ÇÁ ¼¼¸Á ³»Çǰè
  • masticatory musculoskeletal system
    ÀúÀÛ±Ù °ñ°Ý°è
  • masticatory system
    ÀúÀÛ°è
    Ä¡¾Æ, Ä¡ÁÖ Á¶Á÷, ¾Ç°ñ, ÃøµÎÇϾǰüÀý, ÀúÀÛ±Ù ÀÔ¼ú, Çô ¹× À̵é Á¶Á÷°ú °ü·ÃµÈ Ç÷°ü, ½Å°æµé·Î ÀÌ·ç¾îÁø ±â´ÉÀû ´ÜÀ§.
  • mating system
    ±³¹è ½Ã½ºÅÛ
  • metric system
    ¹ÌÅ͹ý
  • microsomal enzyme system
    ¹Ì¼Òü È¿¼Ò°è
  • monochromatic system
    ´Ü»ö°è
  • monocyte-macrophage system
    ´ÜÇÙ±¸-´ë½Ä ¼¼Æ÷°è
  • monovalent system
    ÀϺ¯°è
  • motor system disease
    ¿îµ¿°è Àå¾Ö
  • multiaxial diagnostic system
    ´ÙÃ༺ Áø´Ü ü°è
  • muscular system
    ±ÙÀ° °èÅë, ±Ù°è
  • natural color system
    õ¿¬»ö°è
    ¾Ø´õ½º Çϵ尡 °í¾ÈÇÑ »ö¼ø¹ý. 3¿ø¼Ò·Î ³ª´« »öÀÇ Ã¼°è ³»¿¡¼­ ºûÀÇ Â£°í ¿¶Àº Á¤µµ¸¦ ¿©¼¸ °¡Áö »öÀ» ÀÎÁöÇØ ºñÀ²ÀÇ °³³äÀ¸·Î ºÐ¼®ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • neural enzyme system
    ½Å°æ È¿¼Ò°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
reproductive control agents Substances used either in the prevention or facilitation of pregnancy.
(12 Dec 1998)
glycine agents Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
(12 Dec 1998)
menstruation-inducing agents Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhoea is a secondary result.
(12 Dec 1998)
chelating agents Organic chemicals that form two or more coordination bonds with a central metal ion. Heterocyclic rings are formed with the central metal atom as part of the ring. Some biological systems form metal chelates, e.g., the iron-binding porphyrin group of haemoglobin and the magnesium-binding chlorophyll of plants. They are used chemically to remove ions from solutions, medicinally against microorganisms, to treat metal poisoning, and in chemotherapy protocols.
(12 Dec 1998)
chemical warfare agents Chemicals that are used to cause the disturbance, disease, or death of humans during war.
(12 Dec 1998)
riot control agents, chemical Chemical substances which are employed during a riot in order to control or disperse the rioting parties.
(12 Dec 1998)
cholinergic agents Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of acetylcholine, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of muscarinic agonist, although most modern texts discourage that usage.
(12 Dec 1998)
photosensitizing agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
(12 Dec 1998)
wetting agents A surfactant that renders a surface wettable by water or enhances the spreading of water over the surface; used in foods and cosmetics; important in contrast media; also with contact lenses, dentures, and some prostheses.
Synonym: humectants; hydrating agents.
(12 Dec 1998)
contraceptive agents Chemical substances diminishing the likelihood of or preventing conception. The agents do not include occlusive barriers to prevent the passage of spermatozoa into the uterus (contraceptive devices).
(12 Dec 1998)
contraceptive agents, female Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
(12 Dec 1998)
contraceptive agents, male Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading.
(12 Dec 1998)
haematologic agents Drugs that act on blood and blood-forming organs and those that affect the haemostatic system.
(12 Dec 1998)
haematologic, gastrointestinal, and renal agents A collective grouping for agents that act on the haematopoietic, gastrointestinal, and renal systems.
(12 Dec 1998)
cryoprotective agents Substances capable of protecting against injury due to freezing, as glycerol protects frozen red blood cells.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á